PL341604A1 - Local application ophthalmic preparations containing immunossuppressive agents - Google Patents
Local application ophthalmic preparations containing immunossuppressive agentsInfo
- Publication number
- PL341604A1 PL341604A1 PL98341604A PL34160498A PL341604A1 PL 341604 A1 PL341604 A1 PL 341604A1 PL 98341604 A PL98341604 A PL 98341604A PL 34160498 A PL34160498 A PL 34160498A PL 341604 A1 PL341604 A1 PL 341604A1
- Authority
- PL
- Poland
- Prior art keywords
- immunossuppressive
- agents
- local application
- preparations containing
- ophthalmic preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ19974237A CZ287497B6 (en) | 1997-12-30 | 1997-12-30 | Topic eye preparations containing immunosuppressive substances |
PCT/CZ1998/000054 WO1999034830A1 (en) | 1997-12-30 | 1998-12-17 | Topical ophthalmic preparations containing immunosuppressive agents |
Publications (1)
Publication Number | Publication Date |
---|---|
PL341604A1 true PL341604A1 (en) | 2001-04-23 |
Family
ID=5467853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL98341604A PL341604A1 (en) | 1997-12-30 | 1998-12-17 | Local application ophthalmic preparations containing immunossuppressive agents |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1058560A1 (en) |
JP (1) | JP2002500200A (en) |
AU (1) | AU1481399A (en) |
BG (1) | BG104558A (en) |
CA (1) | CA2317010A1 (en) |
CZ (1) | CZ287497B6 (en) |
HR (1) | HRP20000258A2 (en) |
HU (1) | HUP0004173A2 (en) |
NO (1) | NO20003344D0 (en) |
PL (1) | PL341604A1 (en) |
SK (1) | SK284246B6 (en) |
WO (1) | WO1999034830A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ513111A (en) * | 1998-12-24 | 2003-10-31 | R Tech Ueno Ltd | Agent for treating visual cell function disorder |
US6864232B1 (en) | 1998-12-24 | 2005-03-08 | Sucampo Ag | Agent for treating visual cell function disorder |
TWI324925B (en) * | 2001-08-23 | 2010-05-21 | Novartis Ag | Ophthalmic composition |
PT1539157E (en) | 2002-09-18 | 2013-10-04 | Univ Pennsylvania | Rapamycin for use in inhibiting or preventing choroidal neovascularization |
US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
ES2564194T3 (en) | 2005-02-09 | 2016-03-18 | Santen Pharmaceutical Co., Ltd. | Liquid formulations for the treatment of diseases or ailments |
PL1904056T3 (en) | 2005-07-18 | 2009-09-30 | Minu Llc | Use of a macrolide to restore corneal sensation |
BRPI0707612B8 (en) | 2006-02-09 | 2021-05-25 | Macusight Inc | sealed vessel and liquid formulations contained therein |
US8222271B2 (en) | 2006-03-23 | 2012-07-17 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
AU2014209141B2 (en) | 2013-01-24 | 2018-05-10 | Palvella Therapeutics, Inc. | Compositions for transdermal delivery of mTOR inhibitors |
AU2013384818A1 (en) * | 2013-03-27 | 2015-11-12 | Comprehensive Drug Enterprises, Ltd. | Ophthalmic composition, method for preparing the same, and use of the same |
US11622929B2 (en) | 2016-03-08 | 2023-04-11 | Living Proof, Inc. | Long lasting cosmetic compositions |
AU2018205253B2 (en) | 2017-01-06 | 2022-01-13 | Palvella Therapeutics, Inc. | Anhydrous compositions of mTOR inhibitors and methods of use |
WO2019055440A1 (en) | 2017-09-13 | 2019-03-21 | Living Proof, Inc. | Long lasting cosmetic compositions |
CA3074845A1 (en) | 2017-09-13 | 2019-03-21 | Living Proof, Inc. | Color protectant compositions |
US11000513B2 (en) | 2018-07-02 | 2021-05-11 | Palvella Therapeutics, Inc. | Anhydrous compositions of mTOR inhibitors and methods of use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5051260A (en) * | 1987-07-16 | 1991-09-24 | The Regents Of The University Of California | Method and composition for enhancing the cutaneous penetration of pharmacologically active agents |
US4971800A (en) * | 1988-07-08 | 1990-11-20 | The Regents Of The University Of California | Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents |
US5045317A (en) * | 1987-07-16 | 1991-09-03 | The Regents Of The University Of California | Enhancing the cutaneous penetration of pharmacologically active agents |
-
1997
- 1997-12-30 CZ CZ19974237A patent/CZ287497B6/en not_active IP Right Cessation
-
1998
- 1998-12-14 SK SK1717-98A patent/SK284246B6/en not_active IP Right Cessation
- 1998-12-17 WO PCT/CZ1998/000054 patent/WO1999034830A1/en not_active Application Discontinuation
- 1998-12-17 HU HU0004173A patent/HUP0004173A2/en unknown
- 1998-12-17 JP JP2000527277A patent/JP2002500200A/en not_active Withdrawn
- 1998-12-17 PL PL98341604A patent/PL341604A1/en unknown
- 1998-12-17 EP EP98958793A patent/EP1058560A1/en not_active Withdrawn
- 1998-12-17 AU AU14813/99A patent/AU1481399A/en not_active Abandoned
- 1998-12-17 CA CA002317010A patent/CA2317010A1/en not_active Abandoned
-
2000
- 2000-05-03 HR HR20000258A patent/HRP20000258A2/en not_active Application Discontinuation
- 2000-06-27 NO NO20003344A patent/NO20003344D0/en not_active Application Discontinuation
- 2000-06-27 BG BG104558A patent/BG104558A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU1481399A (en) | 1999-07-26 |
SK171798A3 (en) | 1999-10-08 |
JP2002500200A (en) | 2002-01-08 |
NO20003344L (en) | 2000-06-27 |
HUP0004173A2 (en) | 2001-08-28 |
CZ423797A3 (en) | 1999-07-14 |
WO1999034830A1 (en) | 1999-07-15 |
HRP20000258A2 (en) | 2001-04-30 |
CA2317010A1 (en) | 1999-07-15 |
SK284246B6 (en) | 2004-12-01 |
BG104558A (en) | 2001-02-28 |
NO20003344D0 (en) | 2000-06-27 |
EP1058560A1 (en) | 2000-12-13 |
CZ287497B6 (en) | 2000-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9420657D0 (en) | Contrast agents | |
GB9708484D0 (en) | Therapeutic agents | |
GB9708945D0 (en) | Therapeutic agents | |
SG76535A1 (en) | Pharmaceutical agents | |
PL341604A1 (en) | Local application ophthalmic preparations containing immunossuppressive agents | |
GB9704948D0 (en) | Therapeutic agents | |
GB9702524D0 (en) | Therapeutic agents | |
GB9711753D0 (en) | Therapeutic agents | |
GB9713707D0 (en) | Therapeutic agents | |
EP0920869A4 (en) | Stable aspirin-containing preparations for external use | |
GB9501560D0 (en) | Contrast agents | |
GB9715977D0 (en) | Therapeutic agents | |
GB9711114D0 (en) | Therapeutic agents | |
ZA951232B (en) | Contrast agents | |
PL340555A1 (en) | Preparations containing dissolved paroxetin | |
GB9702392D0 (en) | Therapeutic agents | |
PL338382A1 (en) | Dyeing agents | |
PL336805A1 (en) | Pharmaceutic agents containing thysoxanide and intazoxanide | |
GB9718712D0 (en) | Theraputic Agents | |
GB9700555D0 (en) | Therapeutic agents | |
AU1171099A (en) | Therapeutic agents | |
GB9716463D0 (en) | Therapeutic agents | |
EP1004309A4 (en) | Israpafant-containing water-base preparations | |
HUP0003038A3 (en) | Low dosed 15-desoxyspergualine preparations | |
IL136525A0 (en) | Agents |